Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 22 | Jun' 22 | Mar' 22 | Dec' 21 | Sep' 21 | |
|---|---|---|---|---|---|
| Sales | 170.26 | 159.15 | 176.28 | 165.94 | 168.85 |
| Operating profit | 33.77 | 11.61 | 26.87 | 27.82 | 33.93 |
| Interest | 1.29 | 0.82 | 1.28 | 0.69 | 1.20 |
| Gross profit | 53.51 | 30.22 | 33.24 | 39.20 | 41.33 |
| EPS (Rs) | 1.00 | 0.47 | 0.52 | 0.64 | 0.67 |
Quarterly
results in details
| Sep' 22 | Jun' 22 | Mar' 22 | Dec' 21 | Sep' 21 | |
|---|---|---|---|---|---|
| Other income | 21.03 | 19.43 | 7.65 | 12.07 | 8.60 |
| Stock adjustment | -4.53 | 0.62 | 1.71 | 1.70 | 1.15 |
| Raw material | 91.14 | 79.11 | 83.98 | 79.66 | 85.59 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 13.43 | 13.45 | 15.01 | 15.49 | 15.92 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 36.44 | 54.37 | 48.71 | 41.27 | 32.26 |
| Provisions made | - | - | - | - | - |
| Depreciation | 4.53 | 4.52 | 4.61 | 4.52 | 4.30 |
| Taxation | 8.76 | 6.50 | 7.20 | 8.62 | 9.42 |
| Net profit / loss | 40.23 | 19.21 | 21.43 | 26.06 | 27.60 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 40.42 | 40.93 | 40.93 | 40.93 | 40.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 19.84 | 7.29 | 15.24 | 16.77 | 20.09 |
| GPM (%) | 27.97 | 16.92 | 18.07 | 22.02 | 23.29 |
| NPM (%) | 21.03 | 10.75 | 11.65 | 14.64 | 15.55 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis